TIN-X: Target Importance and Novelty Explorer
Overview
Authors
Affiliations
Motivation: The increasing amount of peer-reviewed manuscripts requires the development of specific mining tools to facilitate the visual exploration of evidence linking diseases and proteins.
Results: We developed TIN-X, the Target Importance and Novelty eXplorer, to visualize the association between proteins and diseases, based on text mining data processed from scientific literature. In the current implementation, TIN-X supports exploration of data for G-protein coupled receptors, kinases, ion channels, and nuclear receptors. TIN-X supports browsing and navigating across proteins and diseases based on ontology classes, and displays a scatter plot with two proposed new bibliometric statistics: Importance and Novelty.
Availability And Implementation: http://www.newdrugtargets.org.
Contact: cbologa@salud.unm.edu.
Metzger V, Cannon D, Yang J, Mathias S, Bologa C, Waller A PeerJ. 2024; 12:e17470.
PMID: 38948230 PMC: 11212617. DOI: 10.7717/peerj.17470.
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models.
Ren F, Aliper A, Chen J, Zhao H, Rao S, Kuppe C Nat Biotechnol. 2024; 43(1):63-75.
PMID: 38459338 PMC: 11738990. DOI: 10.1038/s41587-024-02143-0.
Overview of the Knowledge Management Center for Illuminating the Druggable Genome.
Oprea T, Bologa C, Holmes J, Mathias S, Metzger V, Waller A Drug Discov Today. 2024; 29(3):103882.
PMID: 38218214 PMC: 10939799. DOI: 10.1016/j.drudis.2024.103882.
Illuminating the druggable genome: Pathways to progress.
Sharma K, Colvis C, Rodgers G, Sheeley D Drug Discov Today. 2023; 29(3):103805.
PMID: 37890715 PMC: 10939933. DOI: 10.1016/j.drudis.2023.103805.
Pharos 2023: an integrated resource for the understudied human proteome.
Kelleher K, Sheils T, Mathias S, Yang J, Metzger V, Siramshetty V Nucleic Acids Res. 2023; 51(D1):D1405-D1416.
PMID: 36624666 PMC: 9825581. DOI: 10.1093/nar/gkac1033.